Impaired expression of PPARγ protein contributes to the exaggerated growth of vascular smooth muscle cells in spontaneously hypertensive rats

Life Sciences

Volumn 77, Issue 24, 2005, Pages 3037-3048

  Xiong, Chen ^a,b   Mou, Yongshan ^a   Zhang, Jifeng ^a   Fu, Mingui ^a   Chen, Yuqing E ^a   Akinbami, Mukaila A ^a   Cui, Taixing ^a  

^a MOREHOUSE SCHOOL OF MEDICINE   (United States)

^b HUBEI UNIVERSITY OF MEDICINE   (China)

Author keywords

Hypertension; Peroxisome proliferator activated receptor ; Spontaneously hypertensive rats and gene expression; Vascular smooth muscle cells

Indexed keywords

MESSENGER RNA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CELL GROWTH; CELL PROLIFERATION; CONTROLLED STUDY; MALE; MUSCLE CELL; NONHUMAN; PROTEIN EXPRESSION; RAT; REPORTER GENE; SPONTANEOUSLY HYPERTENSIVE RAT; VASCULAR SMOOTH MUSCLE;

ADENOVIRIDAE; ANIMALS; AORTA; ARTERIES; BLOOD PRESSURE; BLOTTING, NORTHERN; BLOTTING, WESTERN; CELL PROLIFERATION; CELLS, CULTURED; GENES, REPORTER; HYPERTENSION; IMMUNOENZYME TECHNIQUES; MALE; MUSCLE, SMOOTH, VASCULAR; PPAR GAMMA; RATS; RATS, INBRED SHR; RATS, INBRED WKY; RNA, MESSENGER; TRANSFECTION;

EID: 26444559106     PISSN: 00243205     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.lfs.2005.02.032     Document Type: Article

References (43)

1. M. Abe, K. Hasegawa, H. Wada, T. Morimoto, T. Yanazume, T. Kawamura, M. Hirai, Y. Furukawa, and T. Kita GATA-6 is involved in PPARγ-mediated activation of differentiated phenotype in human vascular smooth muscle cells Arteriosclerosis, Thrombosis, and Vascular Biology 23 2003 404 410
2. S. Ameshima, H. Golpon, C.D. Cool, D. Chan, R.W. Vandivier, S.J. Gardai, M. Wick, R.A. Nemenoff, M.W. Geraci, and N.F. Voelkel Peroxisome proliferator-activated receptor gamma (PPARgamma) expression is decreased in pulmonary hypertension and affects endothelial cell growth Circulation Research 92 2003 1162 1169
3. K.B. Atkins, C.A. Northcott, S.W. Watts, and F.C. Brosius Effect of PPARγ ligands on vascular smooth muscle marker expression in hypertensive and normal arteries American Journal of Physiology. Heart and Circulatory Physiology 288 2005 H235 H243
4. I. Barroso, M. Gurnell, V.E.F. Crowley, M. Agostini, J.W. Schwabe, M.A. Soos, G.L. Maslen, T.D. Williams, H. Lewis, A.J. Schafer, V.K. Chatterjee, and S. O'Rahilly Dominant negative mutations in human PPARγ associated with severe insulin resistance, diabetes mellitus and hypertension Nature 402 1999 880 883
5. J. Berger, and D.E. Moller The mechanisms of action of PPARs Annual Review of Medicine 53 2002 409 435
6. M.T. Bihoreau, D. Gauguier, N. Kato, G. Hyne, K. Lindpaintner, and J.P. Rapp A linkage map of the rat genome derived from three F2 crosses Genome Research 7 1997 434 440
7. E. Bonora, S. Kiechl, J. Willeit, F. Oberhollenzer, G. Egger, G. Targher, M. Alberiche, R.C. Bonadonna, and M. Muggeo Prevalence of Insulin Resistance in Metabolic Disorders: the Bruneck Study vol. 47 1998 1643 1649
8. T.A. Buchanan, W.P. Meehan, Y.Y. Jeng, D. Yang, T.M. Chan, J.L. Nadler, S. Scott, R.K. Rude, and W.A. Hsueh Blood pressure lowering by pioglitazone. Evidence for a direct vascular effect The Journal of Clinical Investigation 96 1995 354 360
9. Q.N. Diep, and E.L. Schiffrin Increased expression of peroxisome proliferator-activated receptor-α and -γ in blood vessels of spontaneously hypertensive rats Hypertension 38 2001 249 254
10. Z.E. Floyd, and J.M. Stephens Interferon-gamma-mediated activation and ubiquitin-proteasome-dependent degradation of PPARgamma in adipocytes Journal of Biological Chemistry 277 2002 4062 4068
11. B. Folkow Physiological aspects of primary hypertension Physiological Reviews 62 1982 347 504
12. N. Fukuda Molecular mechanisms of the exaggerated growth of vascular smooth muscle cells in hypertension Journal of Atherosclerosis and Thrombosis 4 1997 65 72
13. M. Fu, J. Zhang, X. Zhu, D.E. Myles, T.M. Willson, X. Liu, and Y.E. Chen Peroxisome proliferator-activated receptor γ inhibits transforming growth factor β-induced connective tissue growth factor expression in human aortic smooth muscle cells by interfering with Smad3 The Journal of Biological Chemistry 276 2001 45888 45894
14. M. Fu, X. Zhu, Q. Wang, J. Zhang, Q. Song, H. Zheng, W. Ogawa, J. Du, and Y.E. Chen Platelet-derived growth factor promotes the expression of peroxisome proliferator-activated receptor γ in vascular smooth muscle cells by a phosphatidylinositol 3-kinase/akt signaling pathway Circulation Research 89 2001 1058 1064
15. M. Fu, J. Zhang, Y. Lin, X. Zhu, M.U. Ehrengruber, and Y.E. Chen Early growth response factor-1 is a critical transcriptional mediator of peroxisome proliferator-activated receptor-gamma 1 gene expression in human aortic smooth muscle cells The Journal of Biological Chemistry 277 2002 26808 26814
16. H.N. Ginsberg Insulin resistance and cardiovascular disease The Journal of Clinical Investigation 106 2000 453 458
17. V. Hadrava, J. Tremblay, and P. Hamet Abnormalities in growth characteristics of aortic smooth muscle cells in spontaneously hypertensive rats Hypertension 13 1989 589 597
18. Y. Hattori, K. Akimoto, and K. Kasai The effects of thiazolidinediones on vascular smooth muscle cell activation by angiotensin II Biochemical and Biophysical Research Communication 273 2000 1144 1149
19. S. Hauser, G. Adelmant, P. Sarraf, H.M. Wright, E. Mueller, and B.M. Spiegelman Degradation of the peroxisome proliferator-activated receptor gamma is linked to ligand-dependent activation Journal of Biological Chemistry 275 2000 18527 18533
20. W.A. Hsueh, and D. Bruemmer Peroxisome proliferator-activated receptor gamma: implications for cardiovascular disease Hypertension 2 2004 297 305
21. J.W. Kemnitz, D.F. Elson, E.B. Roecker, S.T. Baum, R.N. Bergman, and M.D. Meglasson Pioglitazone increases insulin sensitivity, reduces blood glucose, insulin, and lipid levels, and lowers blood pressure in obese, insulin-resistant rhesus monkeys Diabetes 43 1994 204 211
22. T.A. Kotchen Attenuation of hypertension by insulin-sensitizing agents Hypertension 28 1996 219 223
23. R.E. Law, S. Goetz, X.P. Xi, S. Jackson, Y. Kawano, L. Demer, M.C. Fishbein, W.P. Meehan, and W.A. Hsueh Expression and function of PPAR-γ in rat and human vascular smooth muscle cells Circulation 101 2000 1311 1318
24. Z.H. Lin, N. Fukuda, X.Q. Jin, E.H. Yao, T. Ueno, M. Endo, S. Saito, K. Matsumoto, and H. Mugishima Complement 3 is involved in the synthetic phenotype and exaggerated growth of vascular smooth muscle cells from spontaneously hypertensive rats Hypertension 44 2004 42 47
25. N. Marx, U. Schonbeck, M.A. Lazar, P. Libby, and J. Plutzky Peroxisome proliferator-activated receptor γ activators inhibit gene expression and migration in human vascular smooth muscle cells Circulation Research 83 1998 1097 1103
26. N. Marx, T. Bourcier, G.K. Sukhova, P. Libby, and J. Plutzky PPAR-γ activation in human endothelial cells increases plasminogen activator inhibitor type-1 expression: PPAR-γ as a potential mediator in vascular disease Arteriosclerosis, Thrombosis, and Vascular Biology 19 1999 546 551
27. N. Marx, H. Duez, J.C. Fruchart, and B. Staels Peroxisome proliferator-activated receptors and atherogenesis: regulators of gene expression in vascular cells Circulation Research 94 2004 1168 1178
28. M.J. Mulvany, G.L. Baumbach, C. Aalkjaer, and A.M. Heagerty Vascular remodeling Hypertension 28 1996 505 506
29. T. Ogihara, H. Rakugi, H. Ikegami, H. Mikami, and K. Masuo Enhancement of insulin sensitivity by troglitazone lowers blood pressure in diabetic hypertension American Journal of Hypertension 8 1995 316 320
30. G.K. Owens Regulation of differentiation of vascular smooth muscle cells Physiological Reviews 75 1995 487 517
31. H.A. Pershadsingh, J. Szollozi, S. Benson, W.C. Hyun, B.G. Feuerstein, and T.W. Kurtz Effect of ciglitazone on blood pressure and intracellular calcium metabolism Hypertension 21 1993 1020 1023
32. M. Ricote, J. Huang, L. Fajas, A. Li, J. Welch, J. Najib, J.L. Witztum, J. Auwerx, W. Palinski, and C.K. Glass Expression of the peroxisome proliferator-activated receptor gamma in human atherosclerosis and regulation in macrophages by colony stimulating factors and oxidized low density lipoprotein Proceeding of the National Academy of Science of the United State of America 23 1998 7614 7619
33. M. Ricote, A.C. Li, T.M. Willson, C.J. Kelly, and C.K. Glass The peroxisome proliferator-activated receptor-gamma is a negative regulator of macrophage activation Nature 391 1998 79 82
34. R. Ross Atherosclerosis: an inflammatory disease New England Journal of Medicine 340 1999 115 126
35. J. Saltis, and A. Bobik Vascular smooth muscle growth in genetic hypertension: evidence for multiple abnormalities in growth regulatory pathways Journal of Hypertension 10 1992 635 643
36. K. Schoonjans, G. Martin, B. Staels, and J. Auwerx Peroxisome proliferator-activated receptors: orphans with ligands and functions Current Opinion in Lipidology 8 1997 159 166
37. S.M. Schwartz, G.R. Campbell, and J.H. Campbell Replication of smooth muscle cells in vascular disease Circulation Research 58 1986 427 444
38. R. Stamler, J. Stamler, W.F. Riedlinger, G. Algera, and R.H. Roberts Weight and blood pressure. Findings in hypertension screening of 1 million Americans The Journal of American Medical Association 240 1978 1607 1610
39. K. Tamura, Y.E. Chen, M. Horiuchi, Q. Chen, L. Daviet, Z. Yang, M. Lopez-Ilasaca, H. Mu, R.E. Pratt, and V.J. Dzau LXRalpha functions as a cAMP-responsive transcriptional regulator of gene expression Proceedings of the National Academy of Science of the United State of America 97 2000 8513 8518
40. W.A. Thomas, K.T. Lee, and D.N. Kim Cell population kinetics in atherogenesis. Cell births and losses in intimal cell mass-derived lesions in the abdominal aorta of swine Annals of the New York Academy of Sciences 454 1985 305 315
41. P. Tontonoz, E. Hu, and B.M. Spiegelman Stimulation of adipogenesis in fibroblasts by PPARgamma 2, a lipid-activated transcription factor Cell 79 1994 1147 1156
42. Y.S. Tsai, H.J. Kim, N. Takahashi, H.S. Kim, J.R. Hagaman, J.K. Kim, and N. Maeda Hypertension and abnormal fat distribution but not insulin resistance in mice with P465L PPARgamma The Journal of Clinical Investigation 114 2004 240 249
43. S. Yoshioka, H. Nishino, T. Shiraki, K. Ikeda, H. Koike, A. Okuno, M. Wada, T. Fujiwara, and H. Horikoshi Antihypertensive effects of CS-045 treatment in obese Zucker rats Metabolism 42 1993 75 80